Related Experiment Video
Updated: Jul 15, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
When should the seminal vesicles be included in the target volume in prostate radiotherapy?
1Department of Clinical Oncology, Christie Hospital, Wilmslow Road, Manchester M20 4BX, UK. neil.bayman@christie-tr.nwest.nhs.uk
Abstract:
External beam radiotherapy to the prostate and seminal vesicles as a radical treatment for prostate cancer can result in a significant dose being delivered to the rectum. This can be reduced if the target volume includes the prostate only. Using a Medline search, published studies are reviewed to show that the risk of seminal vesicle involvement can be accurately predicted using readily available pre-treatment parameters. We recommend when to exclude the seminal vesicles from a target volume, and the proportion of seminal vesicles that should be included in a target volume in higher risk patients.

